US Stock MarketDetailed Quotes

Corcept Therapeutics (CORT)

Watchlist
  • 32.150
  • -0.240-0.74%
Close Mar 13 16:00 ET
  • 32.160
  • +0.010+0.03%
Post 20:01 ET
3.42BMarket Cap39.21P/E (TTM)

Corcept Therapeutics (CORT) Key Financial Indicators

CORT Earnings per Share (EPS)

According to the latest financial report of Corcept Therapeutics, the latest earnings per share (TTM) for the company is 0.20. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

CORT Free Cash Flow (FCF)

Interested in knowing about Corcept Therapeutics's free cash flow? The latest report shows it as 38.40M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

CORT Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Corcept Therapeutics shows that the company's current ratio is 2.92, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

CORT Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Corcept Therapeutics, the quick ratio is 2.60, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

CORT Return on Equity (ROE)

Want to learn more about the financial health of Corcept Therapeutics? The latest ROE figure is 3.74%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

CORT Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Corcept Therapeutics, the total asset return on investment (ROA) is 2.88%.

Currency: USD

Quarterly

Loading...

CORT Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Corcept Therapeutics's latest financial report to see how their gross margin is doing - currently at 98.74%.

Currency: USD

Quarterly

Loading...

CORT Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Corcept Therapeutics, the net profit margin is 12.02%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More